257 related articles for article (PubMed ID: 11063654)
1. Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential.
Nishikawa A; Iwasaki M; Akutagawa N; Manase K; Yamashita S; Endo T; Kudo R
Gynecol Oncol; 2000 Nov; 79(2):256-63. PubMed ID: 11063654
[TBL] [Abstract][Full Text] [Related]
2. Mouse trophoblastic cell lines: II--Relationship between invasive potential and proteases.
Sharma RK
In Vivo; 1998; 12(2):209-17. PubMed ID: 9627804
[TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer.
Schmalfeldt B; Prechtel D; Härting K; Späthe K; Rutke S; Konik E; Fridman R; Berger U; Schmitt M; Kuhn W; Lengyel E
Clin Cancer Res; 2001 Aug; 7(8):2396-404. PubMed ID: 11489818
[TBL] [Abstract][Full Text] [Related]
5. Macrophage colony-stimulating factor mediates invasion of ovarian cancer cells through urokinase.
Chambers SK; Wang Y; Gertz RE; Kacinski BM
Cancer Res; 1995 Apr; 55(7):1578-85. PubMed ID: 7882368
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte growth factor upregulates E1AF that induces oral squamous cell carcinoma cell invasion by activating matrix metalloproteinase genes.
Hanzawa M; Shindoh M; Higashino F; Yasuda M; Inoue N; Hida K; Ono M; Kohgo T; Nakamura M; Notani K; Fukuda H; Totsuka Y; Yoshida K; Fujinaga K
Carcinogenesis; 2000 Jun; 21(6):1079-85. PubMed ID: 10836994
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
[TBL] [Abstract][Full Text] [Related]
8. A single ets-related transcription factor, E1AF, confers invasive phenotype on human cancer cells.
Kaya M; Yoshida K; Higashino F; Mitaka T; Ishii S; Fujinaga K
Oncogene; 1996 Jan; 12(2):221-7. PubMed ID: 8570199
[TBL] [Abstract][Full Text] [Related]
9. Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth.
Kim KR; Yoshizaki T; Miyamori H; Hasegawa K; Horikawa T; Furukawa M; Harada S; Seiki M; Sato H
Oncogene; 2000 Mar; 19(14):1764-71. PubMed ID: 10777210
[TBL] [Abstract][Full Text] [Related]
10. Antisense E1AF transfection restrains oral cancer invasion by reducing matrix metalloproteinase activities.
Hida K; Shindoh M; Yasuda M; Hanzawa M; Funaoka K; Kohgo T; Amemiya A; Totsuka Y; Yoshida K; Fujinaga K
Am J Pathol; 1997 Jun; 150(6):2125-32. PubMed ID: 9176403
[TBL] [Abstract][Full Text] [Related]
11. Short chain fatty acids inhibit human (SW1116) colon cancer cell invasion by reducing urokinase plasminogen activator activity and stimulating TIMP-1 and TIMP-2 activities, rather than via MMP modulation.
Emenaker NJ; Basson MD
J Surg Res; 1998 Apr; 76(1):41-6. PubMed ID: 9695737
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines.
Afzal S; Lalani el-N ; Foulkes WD; Boyce B; Tickle S; Cardillo MR; Baker T; Pignatelli M; Stamp GW
Lab Invest; 1996 Feb; 74(2):406-21. PubMed ID: 8780160
[TBL] [Abstract][Full Text] [Related]
13. Activation of the ras-mitogen-activated protein kinase pathway and phosphorylation of ets-2 at position threonine 72 in human ovarian cancer cell lines.
Patton SE; Martin ML; Nelsen LL; Fang X; Mills GB; Bast RC; Ostrowski MC
Cancer Res; 1998 May; 58(10):2253-9. PubMed ID: 9605774
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumors.
Huang LW; Garrett AP; Bell DA; Welch WR; Berkowitz RS; Mok SC
Gynecol Oncol; 2000 Jun; 77(3):369-76. PubMed ID: 10831344
[TBL] [Abstract][Full Text] [Related]
15. Increased E1AF expression in mouse fibrosarcoma promotes metastasis through induction of MT1-MMP expression.
Habelhah H; Okada F; Kobayashi M; Nakai K; Choi S; Hamada J; Moriuchi T; Kaya M; Yoshida K; Fujinaga K; Hosokawa M
Oncogene; 1999 Mar; 18(9):1771-6. PubMed ID: 10208438
[TBL] [Abstract][Full Text] [Related]
16. Ets-1 transcription factor-mediated urokinase-type plasminogen activator expression and invasion in glioma cells stimulated by serum and basic fibroblast growth factors.
Kitange G; Shibata S; Tokunaga Y; Yagi N; Yasunaga A; Kishikawa M; Naito S
Lab Invest; 1999 Apr; 79(4):407-16. PubMed ID: 10211993
[TBL] [Abstract][Full Text] [Related]
17. Changes in the expression of matrix proteases and of the transcription factor c-Ets-1 during progression of precancerous bronchial lesions.
Bolon I; Brambilla E; Vandenbunder B; Robert C; Lantuejoul S; Brambilla C
Lab Invest; 1996 Jul; 75(1):1-13. PubMed ID: 8683934
[TBL] [Abstract][Full Text] [Related]
18. Correlated expression of matrix metalloproteinases and ets family transcription factor E1A-F in invasive oral squamous-cell-carcinoma-derived cell lines.
Shindoh M; Higashino F; Kaya M; Yasuda M; Funaoka K; Hanzawa M; Hida K; Kohgo T; Amemiya A; Yoshida K; Fujinaga K
Am J Pathol; 1996 Mar; 148(3):693-700. PubMed ID: 8774124
[TBL] [Abstract][Full Text] [Related]
19. Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma.
Davidson B; Reich R; Goldberg I; Gotlieb WH; Kopolovic J; Berner A; Ben-Baruch G; Bryne M; Nesland JM
Clin Cancer Res; 2001 Mar; 7(3):551-7. PubMed ID: 11297247
[TBL] [Abstract][Full Text] [Related]
20. Tumor cell-matrix interaction: pericellular matrix degradation and metastasis.
Okada Y
Verh Dtsch Ges Pathol; 2000; 84():33-42. PubMed ID: 11217446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]